The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

Progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are progressive disabling neurological conditions usually fatal within 10 years of onset. Little is known about the economic costs of these conditions. This paper reports service use and costs from France, Germany and the UK and...

Full description

Bibliographic Details
Main Authors: Paul McCrone, Christine Anne Mary Payan, Martin Knapp, Albert Ludolph, Yves Agid, P Nigel Leigh, Gilbert Bensimon, NNIPPS Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3169589?pdf=render

Internet

http://europepmc.org/articles/PMC3169589?pdf=render

Similar Items